ARCHIVES

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

January 25, 2013

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

April 25, 2014

Ethics Commission to Meet In L.A.

September 4, 1981

Estrogen Can Benefit Women With Metastatic Breast Cancer

January 30, 2009

ASCO Urges Steps to Eliminate Cancer Care Disparities

May 22, 2009

DCE Board Approves Recompetition Concepts

March 18, 1988